| Biologic Therapy |
1 |
1 |
| CAR-T |
0 |
0.99 |
| Food and Drug Administration (FDA) |
0 |
0.58 |
| Leukemia |
0 |
0.35 |
| Acute Leukemia |
0 |
0.29 |
| Stem Cell Research and Therapy |
0 |
0.28 |
| Acute Lymphoblastic Leukemia |
0 |
0.98 |
| Bone Marrow Transplant |
0 |
0.23 |
| Remission |
0 |
0.23 |
| Bone Marrow |
0 |
0.22 |
| Toxicology |
0 |
0.21 |
| Bone |
0 |
0.15 |
| Grant |
0 |
0.15 |
| Transplantation |
0 |
0.15 |
| Antigens |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Cytokines |
0 |
0.08 |
| Georgia |
0 |
0.08 |
| Hematology |
0 |
0.08 |
| Neurotoxicity |
0 |
0.08 |
| Orphan Drugs |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Refractory |
0 |
0.08 |
| Residual Disease |
0 |
0.08 |